Which has better valuation & earnings, WAT or BRKR?

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 12.66 $642.63M $4.01 101.75 Bruker $3.44B 2.37 -$8.60M -$0.70 N/A

Is WAT or BRKR more profitable?

Waters has a net margin of 3.58% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% Bruker -2.35% 12.47% 4.91%

Does the media refer more to WAT or BRKR?

In the previous week, Waters had 9 more articles in the media than Bruker. MarketBeat recorded 22 mentions for Waters and 13 mentions for Bruker. Bruker's average media sentiment score of 0.71 beat Waters' score of 0.55 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Bruker 7 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, TECH or WAT?

Waters has higher revenue and earnings than Bio-Techne. Bio-Techne is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bio-Techne $1.22B 9.31 $181.86M $1.15 62.71 Waters $3.17B 12.66 $642.63M $4.01 101.75

Is TECH or WAT more profitable?

Bio-Techne has a net margin of 14.97% compared to Waters' net margin of 3.58%. Bio-Techne's return on equity of 13.23% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Bio-Techne 14.97% 13.23% 10.61% Waters 3.58% 11.27% 6.73%

Does the media favor TECH or WAT?

In the previous week, Waters had 13 more articles in the media than Bio-Techne. MarketBeat recorded 22 mentions for Waters and 9 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.26 beat Waters' score of 0.55 indicating that Bio-Techne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waters 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Which has higher valuation and earnings, A or WAT?

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilent Technologies $7.37B 5.62 $1.30B $5.08 28.92 Waters $3.17B 12.66 $642.63M $4.01 101.75

Does the media prefer A or WAT?

In the previous week, Waters had 3 more articles in the media than Agilent Technologies. MarketBeat recorded 22 mentions for Waters and 19 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.68 beat Waters' score of 0.55 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 10 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waters 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Which has preferable earnings & valuation, WAT or DHR?

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 12.66 $642.63M $4.01 101.75 Danaher $24.57B 5.73 $3.61B $5.63 35.58

Is WAT or DHR more profitable?

Danaher has a net margin of 15.95% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Danaher's return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% Danaher 15.95% 11.04% 6.81%

Does the media favor WAT or DHR?

In the previous week, Waters had 2 more articles in the media than Danaher. MarketBeat recorded 22 mentions for Waters and 20 mentions for Danaher. Danaher's average media sentiment score of 1.42 beat Waters' score of 0.55 indicating that Danaher is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Danaher 15 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, WAT or IQV?

IQVIA has higher revenue and earnings than Waters. IQVIA is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 12.66 $642.63M $4.01 101.75 IQVIA $16.98B 2.54 $1.36B $8.06 32.52

Is WAT or IQV more profitable?

IQVIA has a net margin of 8.10% compared to Waters' net margin of 3.58%. IQVIA's return on equity of 30.25% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% IQVIA 8.10% 30.25% 6.54%

Does the media favor WAT or IQV?

In the previous week, Waters and Waters both had 22 articles in the media. IQVIA's average media sentiment score of 1.01 beat Waters' score of 0.55 indicating that IQVIA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive IQVIA 14 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Waters (WAT) Competitors

$408.02 +6.38 (+1.59%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$407.37 -0.65 (-0.16%)

As of 09/11/2026 08:00 PM Eastern

Compare

WAT vs. BRKR, TECH, A, DHR, and IQV

Should you buy Waters stock or one of its competitors? Waters's main competitors and comparable companies include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), and IQVIA (IQV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Waters compare to Bruker?

Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	12.66	$642.63M	$4.01	101.75
Bruker	$3.44B	2.37	-$8.60M	-$0.70	N/A

In the previous week, Waters had 9 more articles in the media than Bruker. MarketBeat recorded 22 mentions for Waters and 13 mentions for Bruker. Bruker's average media sentiment score of 0.71 beat Waters' score of 0.55 indicating that Bruker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Bruker	7 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waters has a net margin of 3.58% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
Bruker	-2.35%	12.47%	4.91%

94.0% of Waters shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.3% of Waters shares are owned by insiders. Comparatively, 27.2% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Waters presently has a consensus target price of $430.10, suggesting a potential upside of 5.41%. Bruker has a consensus target price of $57.00, suggesting a potential upside of 6.68%. Given Bruker's higher probable upside, analysts plainly believe Bruker is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85
Bruker	2 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.43

Waters has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, Bruker has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Summary

Waters beats Bruker on 11 of the 17 factors compared between the two stocks.

How does Waters compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Bio-Techne has a net margin of 14.97% compared to Waters' net margin of 3.58%. Bio-Techne's return on equity of 13.23% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	14.97%	13.23%	10.61%
Waters	3.58%	11.27%	6.73%

Waters has higher revenue and earnings than Bio-Techne. Bio-Techne is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	9.31	$181.86M	$1.15	62.71
Waters	$3.17B	12.66	$642.63M	$4.01	101.75

Bio-Techne has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market. Comparatively, Waters has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

In the previous week, Waters had 13 more articles in the media than Bio-Techne. MarketBeat recorded 22 mentions for Waters and 9 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.26 beat Waters' score of 0.55 indicating that Bio-Techne is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

99.0% of Bio-Techne shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 1.3% of Bio-Techne shares are held by company insiders. Comparatively, 0.3% of Waters shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Bio-Techne presently has a consensus target price of $68.92, suggesting a potential downside of 4.43%. Waters has a consensus target price of $430.10, suggesting a potential upside of 5.41%. Given Waters' stronger consensus rating and higher possible upside, analysts clearly believe Waters is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	0 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.12
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85

Summary

Waters beats Bio-Techne on 10 of the 17 factors compared between the two stocks.

How does Waters compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$7.37B	5.62	$1.30B	$5.08	28.92
Waters	$3.17B	12.66	$642.63M	$4.01	101.75

Agilent Technologies has a net margin of 19.53% compared to Waters' net margin of 3.58%. Agilent Technologies' return on equity of 24.45% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.53%	24.45%	13.09%
Waters	3.58%	11.27%	6.73%

Agilent Technologies currently has a consensus target price of $170.33, suggesting a potential upside of 15.95%. Waters has a consensus target price of $430.10, suggesting a potential upside of 5.41%. Given Agilent Technologies' higher possible upside, equities analysts plainly believe Agilent Technologies is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	5 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.80
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85

Agilent Technologies has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Waters has a beta of 1.19, indicating that its stock price is 19% more volatile than the broader market.

In the previous week, Waters had 3 more articles in the media than Agilent Technologies. MarketBeat recorded 22 mentions for Waters and 19 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.68 beat Waters' score of 0.55 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	10 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

87.4% of Agilent Technologies shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 0.2% of Agilent Technologies shares are held by insiders. Comparatively, 0.3% of Waters shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Agilent Technologies beats Waters on 10 of the 17 factors compared between the two stocks.

How does Waters compare to Danaher?

Waters (NYSE:WAT) and Danaher (NYSE:DHR) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

Waters currently has a consensus price target of $430.10, indicating a potential upside of 5.41%. Danaher has a consensus price target of $228.91, indicating a potential upside of 14.28%. Given Danaher's stronger consensus rating and higher possible upside, analysts clearly believe Danaher is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85
Danaher	0 Sell rating(s)	5 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.88

94.0% of Waters shares are owned by institutional investors. Comparatively, 79.1% of Danaher shares are owned by institutional investors. 0.3% of Waters shares are owned by insiders. Comparatively, 10.8% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	12.66	$642.63M	$4.01	101.75
Danaher	$24.57B	5.73	$3.61B	$5.63	35.58

Danaher has a net margin of 15.95% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
Danaher	15.95%	11.04%	6.81%

In the previous week, Waters had 2 more articles in the media than Danaher. MarketBeat recorded 22 mentions for Waters and 20 mentions for Danaher. Danaher's average media sentiment score of 1.42 beat Waters' score of 0.55 indicating that Danaher is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Danaher	15 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Waters has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, Danaher has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Summary

Danaher beats Waters on 10 of the 17 factors compared between the two stocks.

How does Waters compare to IQVIA?

Waters (NYSE:WAT) and IQVIA (NYSE:IQV) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

IQVIA has a net margin of 8.10% compared to Waters' net margin of 3.58%. IQVIA's return on equity of 30.25% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
IQVIA	8.10%	30.25%	6.54%

In the previous week, Waters and Waters both had 22 articles in the media. IQVIA's average media sentiment score of 1.01 beat Waters' score of 0.55 indicating that IQVIA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
IQVIA	14 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waters has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

Waters presently has a consensus target price of $430.10, suggesting a potential upside of 5.41%. IQVIA has a consensus target price of $243.63, suggesting a potential downside of 7.05%. Given Waters' higher possible upside, research analysts plainly believe Waters is more favorable than IQVIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85
IQVIA	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

94.0% of Waters shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 0.3% of Waters shares are owned by insiders. Comparatively, 1.7% of IQVIA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

IQVIA has higher revenue and earnings than Waters. IQVIA is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	12.66	$642.63M	$4.01	101.75
IQVIA	$16.98B	2.54	$1.36B	$8.06	32.52

Summary

IQVIA beats Waters on 9 of the 16 factors compared between the two stocks.

Get Waters News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WAT vs. The Competition

Export

Metric	Waters	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$39.46B	$9.69B	$7.16B	$23.20B
Dividend Yield	N/A	1.47%	2.56%	3.56%
P/E Ratio	101.75	66.42	272.98	28.69
Price / Sales	12.66	287.71	654.99	102.56
Price / Cash	24.16	26.25	77.04	33.82
Price / Book	9.49	5.28	10.33	4.74
Net Income	$642.63M	$56.67B	$3.49B	$1.07B
7 Day Performance	-0.33%	-2.08%	-3.33%	-1.99%
1 Month Performance	-1.71%	-1.60%	-0.42%	-2.68%
1 Year Performance	38.12%	25.11%	19.22%	10.45%

Waters Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WAT Waters	3.3061 of 5 stars	$408.02 +1.6%	$430.10 +5.4%	+34.7%	$40.12B	$4.64B	101.75	7,900	Positive News Analyst Forecast Gap Down
BRKR Bruker	2.1999 of 5 stars	$58.50 flat	$56.64 -3.2%	+66.6%	$8.91B	$3.44B	N/A	11,085	Analyst Forecast
TECH Bio-Techne	3.495 of 5 stars	$72.43 flat	$68.92 -4.8%	+35.5%	$11.36B	$1.22B	62.98	3,000	Positive News
A Agilent Technologies	4.4604 of 5 stars	$150.60 -0.2%	$170.33 +13.1%	+15.8%	$42.53B	$6.95B	29.65	18,100	Analyst Forecast
DHR Danaher	4.4998 of 5 stars	$207.46 -0.1%	$228.91 +10.3%	+2.6%	$145.98B	$24.57B	36.85	60,000	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WAT) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waters (WAT) Competitors